Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

byBenzinga Newsdesk

October 24, 2022

1 minute read

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

News

Powerbridge Technologies Co., Ltd. Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Benzinga Newsdesk

October 10, 8:41 AM

Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) (the "Company"), a provider of multi-industry technology solutions, today announced that it has received a notification letter from the Listing Qualifications Department

PBTS

Analyst Ratings

Analyst Ratings For MetLife

By Benzinga Insights

February 5, 4:00 PM

6 analysts have expressed a variety of opinions on MetLife (NYSE:MET) over the past quarter, offering a diverse…

MET

AdvanSix Q2 Earnings Beat Consensus Despite Weak Fundamentals

By Lekha Gupta

August 4, 11:51 AM

AdvanSix Inc (NYSE: ASIX) reported a Q2 FY23 sales decline of 27% Y/Y to $427.94 million, beating the

ASIX

Why Harmonic Shares Are Diving Today

By Lekha Gupta

August 1, 2:43 PM

Harmonic Inc (NASDAQ: HLIT) shares are trading lower by around 21% after yesterday's second-quarter results.

HLIT

SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

Related Posts

Powerbridge Technologies Co., Ltd. Regains Compliance With Nasdaq Minimum Bid Price Requirement

Analyst Ratings For MetLife

AdvanSix Q2 Earnings Beat Consensus Despite Weak Fundamentals

Why Harmonic Shares Are Diving Today